These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
609 related items for PubMed ID: 16479516
1. Neisseria meningitidis serogroups A and W-135: carriage and immunity in Burkina Faso, 2003. Mueller JE, Yaro S, Traore Y, Sangare L, Tarnagda Z, Njanpop-Lafourcade BM, Borrow R, Gessner BD. J Infect Dis; 2006 Mar 15; 193(6):812-20. PubMed ID: 16479516 [Abstract] [Full Text] [Related]
2. Meningococcal carriage and immunity in western Burkina Faso, 2003. Yaro S, Traoré Y, Tarnagda Z, Sangaré L, NjanpopLafourcade BM, Drabo A, Findlow H, Borrow R, Nicolas P, Gessner BD, Mueller JE. Vaccine; 2007 Sep 03; 25 Suppl 1():A42-6. PubMed ID: 17559988 [Abstract] [Full Text] [Related]
3. Predictors of immunity after a major serogroup W-135 meningococcal disease epidemic, Burkina Faso, 2002. Raghunathan PL, Jones JD, Tiendrebéogo SR, Sanou I, Sangaré L, Kouanda S, Dabal M, Lingani C, Elie CM, Johnson S, Ari M, Martinez J, Chatt J, Sidibe K, Schmink S, Mayer LW, Kondé MK, Djingarey MH, Popovic T, Plikaytis BD, Carlone GM, Rosenstein N, Soriano-Gabarró M. J Infect Dis; 2006 Mar 01; 193(5):607-16. PubMed ID: 16453255 [Abstract] [Full Text] [Related]
4. Age-specific seroprevalence of serogroup C meningococcal serum bactericidal antibody activity and serogroup A, C, W135 and Y-specific IgG concentrations in the Turkish population during 2005. Ceyhan M, Yildirim I, Balmer P, Riley C, Laher G, Andrews N, Borrow R, Kurt N, Turgut M, Aydogan A, Ecevit C, Uysal G, Schultze V. Vaccine; 2007 Oct 10; 25(41):7233-7. PubMed ID: 17707957 [Abstract] [Full Text] [Related]
5. Association of respiratory tract infection symptoms and air humidity with meningococcal carriage in Burkina Faso. Mueller JE, Yaro S, Madec Y, Somda PK, Idohou RS, Lafourcade BM, Drabo A, Tarnagda Z, Sangaré L, Traoré Y, Fontanet A, Gessner BD. Trop Med Int Health; 2008 Dec 10; 13(12):1543-52. PubMed ID: 18983283 [Abstract] [Full Text] [Related]
6. Meningococcal serogroup W135 in the African meningitis belt: epidemiology, immunity and vaccines. Mueller JE, Borrow R, Gessner BD. Expert Rev Vaccines; 2006 Jun 10; 5(3):319-36. PubMed ID: 16827617 [Abstract] [Full Text] [Related]
7. The rise and fall of epidemic Neisseria meningitidis serogroup W135 meningitis in Burkina Faso, 2002-2005. Traoré Y, Njanpop-Lafourcade BM, Adjogble KL, Lourd M, Yaro S, Nacro B, Drabo A, Parent du Châtelet I, Mueller JE, Taha MK, Borrow R, Nicolas P, Alonso JM, Gessner BD. Clin Infect Dis; 2006 Oct 01; 43(7):817-22. PubMed ID: 16941360 [Abstract] [Full Text] [Related]
8. Persistent low carriage of serogroup A Neisseria meningitidis two years after mass vaccination with the meningococcal conjugate vaccine, MenAfriVac. Kristiansen PA, Ba AK, Ouédraogo AS, Sanou I, Ouédraogo R, Sangaré L, Diomandé F, Kandolo D, Saga IM, Misegades L, Clark TA, Préziosi MP, Caugant DA. BMC Infect Dis; 2014 Dec 04; 14():663. PubMed ID: 25472422 [Abstract] [Full Text] [Related]
9. Quadrivalent meningococcal ACYW-135 glycoconjugate vaccine for broader protection from infancy. Pace D. Expert Rev Vaccines; 2009 May 04; 8(5):529-42. PubMed ID: 19397410 [Abstract] [Full Text] [Related]
10. Quadrivalent meningococcal conjugate vaccines. Pace D, Pollard AJ, Messonier NE. Vaccine; 2009 Jun 24; 27 Suppl 2():B30-41. PubMed ID: 19477560 [Abstract] [Full Text] [Related]
11. Infectious disease. Shortage of meningitis vaccine forces triage in Burkina Faso. Vogel G. Science; 2003 Mar 07; 299(5612):1499-501. PubMed ID: 12624241 [No Abstract] [Full Text] [Related]
16. An outer membrane vesicle vaccine for prevention of serogroup A and W-135 meningococcal disease in the African meningitis belt. Norheim G, Tunheim G, Næss LM, Kristiansen PA, Caugant DA, Rosenqvist E. Scand J Immunol; 2012 Aug 01; 76(2):99-107. PubMed ID: 22537024 [Abstract] [Full Text] [Related]
17. Preclinical immunogenicity and functional activity studies of an A+W meningococcal outer membrane vesicle (OMV) vaccine and comparisons with existing meningococcal conjugate- and polysaccharide vaccines. Tunheim G, Arnemo M, Næss LM, Fjeldheim ÅK, Nome L, Bolstad K, Aase A, Mandiarote A, González H, González D, García L, Cardoso D, Norheim G, Rosenqvist E. Vaccine; 2013 Dec 09; 31(51):6097-106. PubMed ID: 24120679 [Abstract] [Full Text] [Related]
18. Bacterial meningitis in Burkina Faso: surveillance using field-based polymerase chain reaction testing. Parent du Châtelet I, Traore Y, Gessner BD, Antignac A, Naccro B, Njanpop-Lafourcade BM, Ouedraogo MS, Tiendrebeogo SR, Varon E, Taha MK. Clin Infect Dis; 2005 Jan 01; 40(1):17-25. PubMed ID: 15614687 [Abstract] [Full Text] [Related]
19. Meningococcal disease: risk for international travellers and vaccine strategies. Wilder-Smith A. Travel Med Infect Dis; 2008 Jul 01; 6(4):182-6. PubMed ID: 18571105 [Abstract] [Full Text] [Related]
20. Evaluation of the Pastorex meningitis kit for the rapid identification of Neisseria meningitidis serogroups A and W135. Djibo S, Njanpop Lafourcade BM, Boisier P, Moussa A, Kobo G, Sidikou F, Hien A, Bieboure G, Aguilera JF, Parent du Chatelet I, Gessner BD, Chanteau S. Trans R Soc Trop Med Hyg; 2006 Jun 01; 100(6):573-8. PubMed ID: 16406096 [Abstract] [Full Text] [Related] Page: [Next] [New Search]